Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2017 2
2020 6
2021 6
2022 6
2023 7
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Results by year

Filters applied: . Clear all
Page 1
Elevated levels of plasma inactive stromal cell derived factor-1α predict poor long-term outcomes in diabetic patients following percutaneous coronary intervention.
Chikata Y, Iwata H, Miyosawa K, Naito R, Koike T, Moriya S, Yasuda H, Funamizu T, Doi S, Endo H, Wada H, Ogita M, Dohi T, Kasai T, Isoda K, Okazaki S, Miyauchi K, Minamino T. Chikata Y, et al. Cardiovasc Diabetol. 2024 Mar 30;23(1):114. doi: 10.1186/s12933-024-02197-z. Cardiovasc Diabetol. 2024. PMID: 38555431 Free PMC article.
Long-Term Impact of Renin-Angiotensin System Inhibitors for Secondary Prevention in Patients with Chronic Kidney Disease Who Underwent Percutaneous Coronary Intervention.
Fukase T, Dohi T, Nishio R, Takeuchi M, Takahashi N, Chikata Y, Endo H, Doi S, Nishiyama H, Okai I, Iwata H, Okazaki S, Miyauchi K, Daida H, Minamino T. Fukase T, et al. Among authors: chikata y. Kidney Dis (Basel). 2023 Oct 13;10(1):39-50. doi: 10.1159/000532055. eCollection 2024 Feb. Kidney Dis (Basel). 2023. PMID: 38322627 Free PMC article.
Impact of Low-Dose Prasugrel on Platelet Reactivity in Chronic Phase of Post-Percutaneous Coronary Intervention (CHAPERON): a Prospective Cohort Study.
Fukase T, Doi S, Dohi T, Koike T, Nishio R, Yasuda H, Takeuchi M, Takahashi N, Chikata Y, Endo H, Nishiyama H, Okai I, Iwata H, Okazaki S, Daida H, Suwa S, Minamino T, Miyauchi K. Fukase T, et al. Among authors: chikata y. Cardiovasc Drugs Ther. 2023 Apr 25. doi: 10.1007/s10557-023-07454-z. Online ahead of print. Cardiovasc Drugs Ther. 2023. PMID: 37097381
Relationship between coronary high-intensity plaques on T1-weighted imaging by cardiovascular magnetic resonance and vulnerable plaque features by near-infrared spectroscopy and intravascular ultrasound: a prospective cohort study.
Fukase T, Dohi T, Fujimoto S, Nishio R, Nozaki YO, Kudo A, Takeuchi M, Takahashi N, Chikata Y, Endo H, Kawaguchi YO, Doi S, Nishiyama H, Hiki M, Okai I, Iwata H, Yokoyama T, Okazaki S, Miyauchi K, Daida H, Li D, Xie Y, Minamino T. Fukase T, et al. Among authors: chikata y. J Cardiovasc Magn Reson. 2023 Jan 30;25(1):4. doi: 10.1186/s12968-023-00916-1. J Cardiovasc Magn Reson. 2023. PMID: 36710360 Free PMC article.
Favorable Prognosis in Patients with Recovered Pulmonary Hypertension after TAVI: An Analysis of the LAPLACE-TAVI Registry.
Koike T, Iwata H, Chikata Y, Doi S, Naito R, Yasuda H, Funamizu T, Endo H, Miyazaki S, Okazaki S, Higuchi R, Takamisawa I, Sato K, Tamura H, Yokoyama H, Tobaru T, Takanashi S, Tabata M, Minamino T. Koike T, et al. Among authors: chikata y. J Clin Med. 2023 Jan 16;12(2):729. doi: 10.3390/jcm12020729. J Clin Med. 2023. PMID: 36675658 Free PMC article.
Combined impacts of low apolipoprotein A-I levels and reduced renal function on long-term prognosis in patients with coronary artery disease undergoing percutaneous coronary intervention.
Fukase T, Dohi T, Nishio R, Takeuchi M, Takahashi N, Chikata Y, Endo H, Doi S, Nishiyama H, Okai I, Iwata H, Okazaki S, Miyauchi K, Daida H, Minamino T. Fukase T, et al. Among authors: chikata y. Clin Chim Acta. 2022 Nov 1;536:180-190. doi: 10.1016/j.cca.2022.09.020. Epub 2022 Oct 4. Clin Chim Acta. 2022. PMID: 36202225
Paradoxical Long-Term Impact Between Serum Apolipoprotein E and High-Density Lipoprotein Cholesterol in Patients Undergoing Percutaneous Coronary Intervention.
Fukase T, Dohi T, Nishio R, Takeuchi M, Takahashi N, Chikata Y, Endo H, Doi S, Nishiyama H, Okai I, Iwata H, Okazaki S, Miyauchi K, Daida H, Minamino T. Fukase T, et al. Among authors: chikata y. J Atheroscler Thromb. 2023 Jun 1;30(6):611-623. doi: 10.5551/jat.63535. Epub 2022 Aug 5. J Atheroscler Thromb. 2023. PMID: 35934781 Free PMC article.
Low apolipoprotein A1 was associated with increased risk of cancer mortality in patients following percutaneous coronary intervention: A 10-year follow-up study.
Nishiyama H, Funamizu T, Iwata H, Endo H, Chikata Y, Doi S, Wada H, Naito R, Ogita M, Kato Y, Okai I, Dohi T, Kasai T, Isoda K, Okazaki S, Miyauchi K, Minamino T. Nishiyama H, et al. Among authors: chikata y. Int J Cancer. 2022 Nov 1;151(9):1482-1490. doi: 10.1002/ijc.34164. Epub 2022 Jul 7. Int J Cancer. 2022. PMID: 35796324 Free PMC article.
25 results